Swiss National Bank
LENZ

Swiss National Bank’s LENZ Therapeutics LENZ Stock Holding History

Swiss National Bank’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Hold
21,800
– – ﹤0.01% 2300
2025
Q4 		$349K Hold
21,800
– – ﹤0.01% 2306
2025
Q3 		$1.02M Buy
21,800
+500
+2% +$18.4K ﹤0.01% 2159
2025
Q2 		$624K Hold
21,300
– – ﹤0.01% 2286
2025
Q1 		$548K Buy
21,300
+2,400
+13% +$59.1K ﹤0.01% 2327
2024
Q4 		$546K Buy
+18,900
New +$576K ﹤0.01% 2392

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Swiss National Bank's LENZ Position: Q1 2026 in Review

Swiss National Bank held its LENZ Therapeutics (LENZ) position steady in Q1 2026 at 21,800 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #2300.

Swiss National Bank first reported a position in LENZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Swiss National Bank held 21,800 shares of LENZ Therapeutics worth $199K as of Q1 2026.
  • Swiss National Bank left its LENZ Therapeutics share count unchanged in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2300 holding.
  • Swiss National Bank first reported a position in LENZ Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Swiss National Bank's LENZ Therapeutics position peaked at $1.02M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.